172 related articles for article (PubMed ID: 6350388)
1. Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma-associated antigens.
Natali PG; Giacomini P; Russo C; Steinbach G; Fenoglio C; Ferrone S
J Cutan Pathol; 1983 Aug; 10(4):225-37. PubMed ID: 6350388
[No Abstract] [Full Text] [Related]
2. Structure and epitope specificity of human melanoma-associated oncofetal antigen gp87 analyzed with monoclonal antibodies.
Liao SK; Leung WC; Kanamaru T
J Dermatol; 1985 Apr; 12(2):117-28. PubMed ID: 2411774
[No Abstract] [Full Text] [Related]
3. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP
Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
5. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
[TBL] [Abstract][Full Text] [Related]
6. Immune response to autologous human melanoma: implication of class I and II MHC products.
Fossati G; Anichini A; Taramelli D; Balsari A; Gambacorti-Passerini C; Kirkwood JM; Parmiani G
Biochim Biophys Acta; 1986 Dec; 865(3):235-51. PubMed ID: 3539196
[No Abstract] [Full Text] [Related]
7. HLA-DR antigen expression in primary melanomas of the skin.
Bröcker EB; Suter L; Sorg C
J Invest Dermatol; 1984 Mar; 82(3):244-7. PubMed ID: 6366074
[TBL] [Abstract][Full Text] [Related]
8. Peptide vaccine trials for melanoma: preclinical background and clinical results.
Talebi T; Weber JS
Semin Cancer Biol; 2003 Dec; 13(6):431-8. PubMed ID: 15001162
[No Abstract] [Full Text] [Related]
9. Immunohistological detection of human malignant melanoma using monoclonal antibody to a melanoma-associated antigen.
Kageshita T; Johno M; Ono T; Arao T; Imai K
Arch Dermatol Res; 1985; 277(4):334-6. PubMed ID: 3890772
[No Abstract] [Full Text] [Related]
10. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
Hellström I; Brown JP; Hellström KE
Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
[TBL] [Abstract][Full Text] [Related]
11. The impact of monoclonal antibodies on the study of human malignant melanoma.
Natali PG; Aguzzi A; Veglia F; Imai K; Burlage RS; Giacomini P; Ferrone S
J Cutan Pathol; 1983 Dec; 10(6):514-28. PubMed ID: 6198345
[No Abstract] [Full Text] [Related]
12. Phenotypic dynamics of tumor progression in human malignant melanoma.
Bröcker EB; Suter L; Brüggen J; Ruiter DJ; Macher E; Sorg C
Int J Cancer; 1985 Jul; 36(1):29-35. PubMed ID: 3860479
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
14. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
Herlyn M; Steplewski Z; Atkinson BF; Ernst CS; Koprowski H
Hybridoma; 1982; 1(4):403-11. PubMed ID: 6765323
[TBL] [Abstract][Full Text] [Related]
16. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
Harper JR; Bumol TF; Reisfeld RA
Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
[TBL] [Abstract][Full Text] [Related]
17. Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma.
Ernstoff MS; Duray P; Stenn K; Kirkwood JM
J Invest Dermatol; 1985 May; 84(5):430-2. PubMed ID: 3889169
[TBL] [Abstract][Full Text] [Related]
18. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
19. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases.
van Duinen SG; Ruitter DJ; Ferrone S
J Pathol; 1986 Aug; 149(4):339-48. PubMed ID: 3531448
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]